Intravacc is an experienced R&D organization with a proven track record in vaccinology of over 100 years.
Intravacc has raised $633K in total funding. The most recent round was Grant. The last funding was announced in January 2024.
Intravacc's investors include European Union, CARB-X.
Intravacc is headquartered in Bilthoven, The Netherlands.
Intravacc is an experienced R&D organization with a proven track record in vaccinology of over 100 years.
Intravacc is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Intravacc — Funding & Investors." VCBacked, January 11, 2024, https://www.vcbacked.co/company/intravacc. Accessed July 20, 2026.
VCBacked. (2024). Intravacc — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/intravacc
{{cite web |title=Intravacc — Funding & Investors |url=https://www.vcbacked.co/company/intravacc |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated